Konrad H. Stopsack
Research Scientists

Konrad H. Stopsack

Research Scientist




I am a molecular and clinical epidemiologist with a focus on cancer epidemiology and a background as a board-certified internal medicine physician. My main research interest is how potentially modifiable exposures cause solid tumors through genomic heterogeneity and influence cancer progression. I am passionate about combining well-defined observational studies and state-of-the-art genomics in order to guide cancer prevention and treatment. My methodologic and teaching interests include application and further development of epidemiologic methods for high-dimensional biomarker studies and clinical studies.

MD, 2013, Medicine
University of Freiburg, Freiburg, Germany

MPH, 2014, Biostatistics and Epidemiology
Harvard School of Public Health, Boston, MA

Residency, Board certification, 2017, Internal Medicine
Mayo Clinic, Rochester, MN

Postdoctoral training, 2021, Cancer Epidemiology
Memorial Sloan Kettering Cancer Center, New York, NY


Clonal hematopoiesis and risk of prostate cancer in large samples of European ancestry men.

Wang A, Xu Y, Yu Y, Nead KT, Kim T, Xu K, Dadaev T, Saunders E, Sheng X, Wan P, Pooler L, Xia LY, Chanock S, Berndt SI, Gapstur SM, Stevens V, Albanes D, Weinstein SJ, Gnanapragasam V, Giles GG, Nguyen-Dumont T, Milne RL, Pomerantz MM, Schmidt JA, Stopsack KH, Mucci LA, Catalona WJ, Hetrick KN, Doheny KF, MacInnis RJ, Southey MC, Eeles RA, Wiklund F, Kote-Jarai Z, de Smith AJ, Conti DV, Huff C, Haiman CA, Darst BF.

Hum Mol Genet. 2023 01 13. 32(3):489-495. PMID: 36018819